UNIS Apples, page-8

Hi Archer
My thoughts are that the lawsuits will amount to nothing that will affect UNIS.
Even as precarious the financial status is, I would still invest all and 1 week ago I sold all and re-bought them same day. I wanted to determine the value of the shares owned and establish a CGT loss, for CenterLink and Taxation purposes.
I never expected to be able to claim part aged pension, but it's nice to know that my weekly income is covered whilst the share price grows. If it goes under-then so be it- but I am still confident it will work out.
UNIS has doubled its clean rooms (I believe) from initially having 11.
I believe over 200 staff are on the production side.
Doing what?
well the latest info that I have is that 3 Unifill production lines are installed.
Wearables are being hand assembled and a 5 million production line is being installed.
5 million by $25 = $125 million each year and 40% profit =$52 million profit each and every year for each line installed.
3 Unifill production lines can produce 600 million syringes- some of those are about 25 cent profit and others are up to $4 profit.
The Opti range will produce a premium profit.
Amgen scrutinized the books and products and they bought in.
The FDA has been slow to work out the rules for Biosimilars, but I believe Europe is well advanced and approvals granted.
Like others I am disappointed that I haven't bought at 6 cents, but it's only production figures that is allowing the shorting to succeed.
As for BREXIT- well it's a buyers market.
Apples in trouble in China and is running out of steam trying to out smart the competition.
UNIS has to just get a Financial Partner.
All IMO